Reduced expression of FBXW7 has been reported to be correlated with worse outcomes in several human cancers, including gastric cancer [77], colorectal cancer [78], cervical squamous carcinoma [79], glioma [80], and prostate cancer [81]. The gene discussed is FBXW7; the disease is central nervous system cancer.